Securian Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$682K Buy
8,768
+100
+1% +$6.82K 0.02% 521
2026
Q1
$560K Buy
8,668
+157
+2% +$11.1K 0.02% 559
2025
Q4
$573K Sell
8,511
-249
-3% -$16.7K 0.02% 548
2025
Q3
$642K Sell
8,760
-624
-7% -$41.5K 0.02% 595
2025
Q2
$488K Sell
9,384
-234
-2% -$13.3K 0.01% 695
2025
Q1
$614K Hold
9,618
0.02% 587
2024
Q4
$460K Sell
9,618
-232
-2% -$11.9K 0.01% 717
2024
Q3
$564K Sell
9,850
-301
-3% -$17.3K 0.02% 644
2024
Q2
$532K Sell
10,151
-705
-6% -$30.9K 0.02% 651
2024
Q1
$442K Sell
10,856
-217
-2% -$8.13K 0.01% 744
2023
Q4
$409K Sell
11,073
-100
-0.9% -$3.77K 0.01% 765
2023
Q3
$427K Sell
11,173
-557
-5% -$22.8K 0.01% 716
2023
Q2
$423K Sell
11,730
-584
-5% -$19.9K 0.01% 744
2023
Q1
$470K Sell
12,314
-111
-0.9% -$5.21K 0.01% 705
2022
Q4
$707K Sell
12,425
-107
-0.9% -$5.48K 0.02% 555
2022
Q3
$496K Hold
12,532
0.01% 644
2022
Q2
$551K Sell
12,532
-100
-0.8% -$4.33K 0.01% 670
2022
Q1
$504K Buy
12,632
+23
+0.2% +$819 0.01% 753
2021
Q4
$507K Sell
12,609
-155
-1% -$5.79K 0.01% 769
2021
Q3
$519K Buy
12,764
+464
+4% +$19.4K 0.01% 756
2021
Q2
$559K Buy
12,300
+355
+3% +$15.7K 0.01% 746
2021
Q1
$498K Sell
11,945
-100
-0.8% -$4.57K 0.01% 769
2020
Q4
$514K Buy
+12,045
New +$433K 0.01% 707

Other funds holding HALO

Securian Asset Management's HALO Position: Q2 2026 in Review

Securian Asset Management increased its Halozyme (HALO) stake by 1.2% in Q2 2026, buying an estimated $6.82K and bringing the position to 8,768 shares worth $682K. The position accounts for 0.02% of the portfolio, ranked #521.

Securian Asset Management first reported a position in HALO in Q4 2020 and has held it in 23 quarters since. The position peaked at $707K in Q4 2022. 342 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

  • Securian Asset Management held 8,768 shares of Halozyme worth $682K as of Q2 2026.
  • Securian Asset Management bought 100 Halozyme shares in Q2 2026, an estimated $6.82K.
  • Halozyme made up 0.02% of Securian Asset Management's portfolio in Q2 2026, its #521 holding.
  • Securian Asset Management first reported a position in Halozyme in Q4 2020 and has held it in 23 quarters since.
  • Securian Asset Management's Halozyme position peaked at $707K in Q4 2022.
  • 342 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Securian Asset Management's 13F filing for Q2 2026, filed 23 Jul 2026.